Avistone Biotechnology Co., Ltd.
Clinical trials sponsored by Avistone Biotechnology Co., Ltd., explained in plain language.
-
New pill targets tough cancers in first human trial
Disease control OngoingThis is a first-in-human study testing a new oral medication called ANS014004 for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it mig…
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New targeted pill challenges chemo in major lung cancer trial
Disease control ENROLLING_BY_INVITATIONThis study is comparing a new oral drug, PLB1004, to standard platinum-based chemotherapy for people with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called an EGFR exon 20 insertion. The main goal is to see if PLB1004 is better at controlling t…
Phase: PHASE3 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC